Ditchcarbon
  • Customers
  1. Organizations
  2. OptiNose, Inc.
Public Profile
Pharmaceutical Preparation Manufacturing
US
updated 5 months ago

OptiNose, Inc.

Company website

OptiNose, Inc., a pioneering biopharmaceutical company headquartered in the United States, focuses on innovative solutions for patients suffering from chronic sinusitis and other nasal conditions. Founded in 2010, OptiNose has made significant strides in the industry, particularly with its unique delivery systems that enhance the efficacy of medications. The company’s flagship products, including the Xhance nasal spray, leverage advanced technology to improve drug absorption and patient compliance. With a commitment to addressing unmet medical needs, OptiNose has established a strong market position, recognised for its contributions to the field of nasal therapeutics. As it continues to expand its operational reach, OptiNose remains dedicated to transforming the treatment landscape for patients worldwide.

DitchCarbon Score

How does OptiNose, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

25

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

28

Industry Benchmark

OptiNose, Inc.'s score of 25 is lower than 70% of the industry. This can give you a sense of how well the company is doing compared to its peers.

30%

Let us know if this data was useful to you

OptiNose, Inc.'s reported carbon emissions

OptiNose, Inc., headquartered in the US, currently does not report any specific carbon emissions data, as indicated by the absence of emissions figures in kg CO2e. Furthermore, there are no documented reduction targets or climate pledges associated with the company. As a result, OptiNose's climate commitments and initiatives remain unclear, and there is no inherited emissions data from a parent or related organisation. The company has not established any Science-Based Targets Initiative (SBTi) reduction targets or other industry-standard climate commitments at this time. In the context of the pharmaceutical industry, where OptiNose operates, many companies are increasingly focusing on sustainability and carbon reduction strategies. However, without specific data or commitments from OptiNose, it is challenging to assess their position in this evolving landscape.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. OptiNose, Inc.'s primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for OptiNose, Inc. is in US, which has a low grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

OptiNose, Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Merck Sharp & Dohme LLC

US
•
Pharmaceutical Preparation Manufacturing
Updated 2 days ago

Astra Zeneca

GB
•
Pharmaceutical Preparation Manufacturing
Updated 1 day ago

Genentech USA, Inc.

US
•
Pharmaceutical Preparation Manufacturing
Updated 14 days ago

Novartis Pharmaceuticals Corporation

US
•
Pharmaceutical Preparation Manufacturing
Updated 14 days ago

Chiesi Ltd.

GB
•
Pharmaceutical Preparation Manufacturing
Updated 14 days ago

Boehringer Ingelheim Pharmaceuticals, Inc.

US
•
Pharmaceutical Preparation Manufacturing
Updated 14 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v250809.1
enquiries@ditchcarbon.com+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
Verified byUL Verified
Partnered withCDP
ProductPortalDataDocumentationIntegrationsChangelogPricing
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesMethodologyBlogFAQOrganizationsIndustriesSBTI APITrust Centre
AboutTeamCareersLicense AgreementPrivacy